Form D · Biotechnology
IceCure Medical Ltd.
Caesarea, L3 · CIK 0001584371
Offering snapshot reported Jun 25, 2026 · SEC filing
- Reported sold
- $16.5M Offering amount: $16.5M
- Investors reported
- 1 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Jun 17, 2026 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Jun 25, 2026 | Initial | $16,500,000 | No comparison | 1 | SEC filing |
| Mar 31, 2026 | Initial | $4,000,000 | No comparison | 5 | SEC filing |
| Sep 12, 2013 | Initial | $4,000,000 | No comparison | 16 | SEC filing |
Offering details
- Securities
- Option to acquire, Security to be acquired
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $385K
- Finders' fees
- $0
- Form D file number
- 021-588649
The total offering amount reflects the total gross proceeds to be received by the Company, assuming cash exercise of all pre-funded warrants and ordinary warrants.
Sales compensation recipients
Scroll to see all columns →
| Recipient | CRD | Associated broker-dealer |
|---|---|---|
| A.G.P./Alliance Global Partners | 000008361 |
Source: Form D, filed Jun 25, 2026. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No matching detailed fund disclosure was found in the latest imported ADV filings. This does not establish that the issuer has no adviser.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Nir Bachman | Executive |
| Doron Birger | Director |
| Vincent Chun Hung Chan | Director |
| Doron Cohen | Executive |
| Merav Nir Dotan | Executive |
| Meirav Dudek | Executive |
| Alon Dumanis | Director |
| Adi Goldin | Director |
| Yaacov Goldman | Director |
| Shad Good | Executive |
| Yehezkel Himelfarb | Director, Executive |
| Yang Huang | Director |
| William Irby | Executive |
| Shay Levav | Executive |
| Sharon Levita | Director |
| Yonatan Malca | Director |
| Ron Mayron | Director |
| Naum Muchnik | Executive |
| Elka Nir | Director |
| Meir Peleg | Executive |
| Elizabeth Sadka | Executive |
| Eyal Shamir | Director, Executive |
| Oded Tamir | Director |
| Tlalit Bussi Tel Tzure | Executive |
| Ronen Tsimerman | Executive |
Issuer details
Industry: Biotechnology (See others in industry)
Address:
7 Ha'eshel Street
Caesarea, L3, 3079504
Phone: +972.4.6230333
Caesarea, L3, 3079504
Phone: +972.4.6230333